No. |
Chromosome Location |
Chromatin state |
Cell line |
Tissue |
1 |
chr6:106945600-106957600 |
Weak transcription |
Breast Myoepithelial Primary Cells |
Breast
|
2 |
chr6:106950000-106957800 |
Weak transcription |
Pancreas |
Pancrea
|
3 |
chr6:106951200-106957400 |
Weak transcription |
Foreskin Keratinocyte Primary Cells skin03 |
Skin
|
4 |
chr6:106951400-106957800 |
Weak transcription |
Foreskin Keratinocyte Primary Cells skin02 |
Skin
|
5 |
chr6:106952600-106957600 |
Weak transcription |
H1 Derived Mesenchymal Stem Cells |
ES cell derived
|
6 |
chr6:106955400-106957400 |
Weak transcription |
Esophagus |
oesophagus
|
7 |
chr6:106955600-106957400 |
Weak transcription |
HMEC |
breast
|
8 |
chr6:106956400-106957600 |
Enhancers |
Mesenchymal Stem Cell Derived Adipocyte Cultured Cells |
ES cell derived
|
9 |
chr6:106956400-106957600 |
Enhancers |
Adipose Derived Mesenchymal Stem Cell Cultured Cells |
ES cell derived
|
10 |
chr6:106956600-106957400 |
Enhancers |
Primary monocytes fromperipheralblood |
blood
|
11 |
chr6:106956600-106957400 |
Enhancers |
Adipose Nuclei |
Adipose
|
12 |
chr6:106956600-106957600 |
Enhancers |
Primary neutrophils fromperipheralblood |
blood
|
13 |
chr6:106956600-106958000 |
Enhancers |
Breast variant Human Mammary Epithelial Cells (vHMEC) |
Breast
|
14 |
chr6:106956800-106957800 |
Bivalent Enhancer |
Fetal Intestine Large |
intestine
|
15 |
chr6:106956800-106957800 |
Bivalent Enhancer |
NHLF |
lung
|
16 |
chr6:106956800-106959600 |
Flanking Active TSS |
Monocytes-CD14+_RO01746 |
blood
|
17 |
chr6:106957000-106957400 |
Bivalent Enhancer |
HUES64 Cell Line |
embryonic stem cell
|
18 |
chr6:106957000-106957400 |
Bivalent Enhancer |
iPS-20b Cell Line |
embryonic stem cell
|
19 |
chr6:106957000-106957400 |
Enhancers |
Primary B cells from peripheral blood |
blood
|
20 |
chr6:106957000-106957400 |
Enhancers |
Primary hematopoietic stem cells short term culture |
blood
|
21 |
chr6:106957000-106957400 |
Enhancers |
Primary Natural Killer cells fromperipheralblood |
blood
|
22 |
chr6:106957000-106957400 |
Enhancers |
Primary hematopoietic stem cells G-CSF-mobilized Female |
--
|
23 |
chr6:106957000-106957600 |
Enhancers |
Primary T killer naive cells fromperipheralblood |
blood
|
24 |
chr6:106957000-106957600 |
Flanking Active TSS |
Dnd41 |
blood
|
25 |
chr6:106957000-106957600 |
Bivalent Enhancer |
NH-A |
brain
|
26 |
chr6:106957000-106957800 |
Bivalent Enhancer |
Fetal Lung |
lung
|
27 |
chr6:106957000-106958000 |
Bivalent Enhancer |
IMR90 fetal lung fibroblasts Cell Line |
lung
|
28 |
chr6:106957000-106959200 |
Bivalent/Poised TSS |
HUES48 Cell Line |
embryonic stem cell
|
29 |
chr6:106957000-106962800 |
Flanking Active TSS |
Primary hematopoietic stem cells G-CSF-mobilized Male |
--
|
30 |
chr6:106957200-106957400 |
Flanking Bivalent TSS/Enh |
iPS-18 Cell Line |
embryonic stem cell
|
31 |
chr6:106957200-106957400 |
Enhancers |
Foreskin Fibroblast Primary Cells skin01 |
Skin
|
32 |
chr6:106957200-106957400 |
Enhancers |
Thymus |
Thymus
|
33 |
chr6:106957200-106957600 |
Enhancers |
Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells |
embryonic stem cell
|
34 |
chr6:106957200-106957600 |
Weak transcription |
NHEK |
skin
|
35 |
chr6:106957200-106958000 |
Flanking Active TSS |
Primary T cells from cord blood |
blood
|
36 |
chr6:106957200-106958800 |
Bivalent/Poised TSS |
iPS-15b Cell Line |
embryonic stem cell
|
37 |
chr6:106957200-106958800 |
Weak transcription |
Hela-S3 |
cervix
|
38 |
chr6:106957200-106960000 |
Flanking Active TSS |
Primary B cells from cord blood |
blood
|
39 |
chr6:106957200-106961200 |
Bivalent/Poised TSS |
HUES6 Cell Line |
embryonic stem cell
|
40 |
chr6:106957200-106961600 |
Bivalent/Poised TSS |
ES-I3 Cell Line |
embryonic stem cell
|
41 |
chr6:106957200-106962800 |
Flanking Active TSS |
Primary hematopoietic stem cells |
blood
|